NovelStem International (NovelStem International) Total Receivables : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is NovelStem International Total Receivables?

NovelStem International's Total Receivables for the quarter that ended in Dec. 2023 was $0.00 Mil.

NovelStem International Total Receivables Historical Data

The historical data trend for NovelStem International's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovelStem International Total Receivables Chart

NovelStem International Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec21

Dec22

Dec23

Total Receivables

Get a 7-Day Free Trial

0.52

1.49

0.01

NovelStem International Quarterly Data
	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Receivables	Get a 7-Day Free Trial															0.01	-	-	-	-

NovelStem International Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

NovelStem International Total Receivables Related Terms

Thank you for viewing the detailed overview of NovelStem International's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

NovelStem International (NovelStem International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NovelStem International Corp (OTCPK:NSTM) » Definitions » Total Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

2255 Glades Road, Suite 221A, Boca Raton, FL, USA, 33431

Website

https://www.novelstem.com

NovelStem International Corp owns novel stem-cell-based diagnostic technology for predicting patients' resistance to cancer therapies. The technology is also being used for genetic research related to other medical therapies.

Executives

Baker Street Capital Management, Llc	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Vadim Perelman	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Baker Street Capital L.p.	10 percent owner	1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067
Stephen Gans	director, 10 percent owner	14850 NW 44TH COURT, OPA LOCKA FL 33054
Shannon River Partners Lp	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Shannon River Fund Management Co Llc	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Shannon River Partners Ii, Lp	10 percent owner	850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022
Doonbeg Fund Lp	10 percent owner	850 THIRD AVE, 13TH FLOOR, New York ny 10022
Spencer M. Waxman	director	C/O SHANNON RIVER PARTNERS, 800 THIRD AVENUE 30TH FLOOR, NEW YORK NY 10022
Stanley Morgan	10 percent owner	1585 BROADWAY, NEW YORK NY 10036
Robert D. Epstein	director	2255 GLADES ROAD, BOCA RATON FL 33431
Coghill Capital Management Llc	10 percent owner	233 SOUTH WACKER DRIVE, SUITE 8439, CHICAGO IL 60606
Ccm Master Fund Ltd	10 percent owner	C/O MORGAN STANLEY FUND SERVICES (CAYMAN, LTD CENTURY YARD CRICKET SQ HUTCHINGS DR, PO BOX 2681 GEORGE TOWN E9 00000
Clint D Coghill	10 percent owner
Scott Gomez	officer: Chief Accounting Officer

NovelStem International (NovelStem International) Headlines

From GuruFocus

Hollywood Media Corp. Reports Operating Results (10-Q)

By gurufocus • 05-11-2009

Hollywood Media Corp. Reports Operating Results (10-K/A)

By gurufocus 10qk • 04-30-2010

Hollywood Media Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 05-17-2010

NewStem Announces $4 million Seed Investment

By PRNewswire PRNewswire • 07-16-2018